Related Experiment Video
Updated: Oct 2, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Relationship between Using Fibrate and Open-Angle Glaucoma in Hyperlipidemic Patients: A Population-Based Cohort
Yung-En Tsai1,2, Yi-Hao Chen2, Chien-An Sun3,4
1Department of Ophthalmology, Kaohsiung Armed Forces General Hospital, Kaohsiung 802, Taiwan.
Long-term fibrate use, over seven years, was associated with a reduced risk of open-angle glaucoma (OAG) in hyperlipidemic patients. This finding suggests a potential protective effect of fibrates against OAG development.
Area of Science:
- Ophthalmology
- Pharmacology
- Epidemiology
Background:
- Hyperlipidemia is a common condition requiring lipid-lowering therapy.
- Open-angle glaucoma (OAG) is a leading cause of irreversible blindness.
- The potential ocular side effects of lipid-lowering medications warrant investigation.
Purpose of the Study:
- To investigate the association between fibrate use and the risk of developing open-angle glaucoma (OAG).
- To analyze this risk specifically in patients diagnosed with hyperlipidemia.
Main Methods:
- Retrospective cohort study utilizing the National Health Insurance Research Database (NHIRD).
- Inclusion of 10,011 patients using fibrates and 40,044 controls over a 16-year period.
- Statistical analyses included Fisher's exact test, Pearson chi-square test, adjusted hazard ratios (aHR), and Kaplan-Meier analysis.
Main Results:
- Fibrate use was associated with a significantly lower incidence of OAG (aHR = 0.624, p = 0.007).
- The incidence rates were 463.02 per 100,000 person-years for fibrate users versus 573.65 for non-users.
- Kaplan-Meier analysis indicated a significantly lower cumulative risk of OAG in the fibrate group after seven years of use (log-rank test p = 0.050).
Conclusions:
- Prolonged use of fibrates (over seven years) may be linked to a reduced risk of open-angle glaucoma in hyperlipidemic individuals.
- The findings suggest a potential protective role of fibrates against OAG.
- Further prospective research is recommended to confirm and elucidate this relationship.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

